WednesdayDec 28, 2022 12:45 pm

Lift Vancouver 2023 Dedicated to Uplifting the Cannabis Community In Canada

It’s time for cannabis industry leaders and enthusiasts in Canada, and across North America, to gather and refresh their cannabis knowledge and connections at Lift Vancouver 2023 taking place at the Vancouver Convention Centre from January 12-14, 2023. Lift is Canada’s #1 Cannabis Conference and Trade Show, engaged in curating and presenting quality cannabis content to audiences throughout the full cannabis ecosystem while establishing collaborative relationships among them. Lift is a premier networking arena in Canada and beyond for cannabis traders, enthusiasts, industry professionals, consumers, media, and investors, to get direct access to B2B buyers and retailers. The Lift Cannabis…

Continue Reading

WednesdayDec 28, 2022 12:00 pm

CubCrafters Inc. Achieves Key Milestones in 2022, Continuing Growth Since Inception

CubCrafters is a producer of best-in-class backcountry aircraft made under the light sport, experimental, and FAA-certified (Part 23 certified) aircraft categories In 2022, the company achieved several milestones, including filing and receiving qualification for a public offering under the Regulation A+ exemption, marking the first time the company has opened to outside investment in its 42-year history The company aims to raise $50 million, channeling the proceeds from the offering toward accelerating manufacturing, enhancing manufacturing capabilities, furthering innovation, and improving customer service CubCrafters also released a new, improved engine for its Experimental aircraft In addition, CubCrafters announced its flagship XCub…

Continue Reading

WednesdayDec 28, 2022 11:15 am

Aditxt Inc. (NASDAQ: ADTX) Announces Goal of First-in-Human Trials for Drug Candidate ADI(TM)-100 with a Focus on Psoriasis

Dr. Joachim-Friedrich Kapp is leading Aditxt’s ADI(TM) immune modulation technology development toward clinical trials The global psoriasis therapeutics market was valued at $22.9 billion in 2021 and is projected to reach $55.8 billion by 2031, growing at a CAGR of 9.3% The primary goal of the first-in-human clinical trial is to demonstrate the safety of Aditxt’s ADI(TM) technology; in addition, the trial has been designed to evaluate the ability of ADI(TM) to restore immune tolerance Aditxt (NASDAQ: ADTX), a biotech innovation company developing and commercializing technologies with a focus on monitoring and modulating the immune system, is focused on mapping…

Continue Reading

WednesdayDec 28, 2022 10:30 am

USDA’s Inclusion of Hemp Data in the 2022 Census for Agriculture is seen as Another Boost to the Cannabis Sector, and REZYFi, Inc. is Set to Benefit from It

The USDA is set to include hemp data in its 2022 Census of Agriculture, another indication of the ongoing growth in support of the overall cannabis industry, benefitting related mortgage origination and financing company REZYFi, Inc. The legal marijuana industry is set to hit 53% in 2026, a 60% growth, with international legal marijuana sales expected to hit $130 billion by 2030 REZYFi is confident that this move by the USDA will yield further growth in the cannabis sector, supporting demand for its product offerings as it expands to additional states throughout the U.S. In 2014, the Farm Bill, regarded…

Continue Reading

WednesdayDec 28, 2022 9:45 am

CNS Pharmaceuticals, Inc. (NASDAQ: CNSP) Continues to See Growth in Patient Enrollment for Brain Cancer Drug Candidate Global Clinical Trial

CNS Pharmaceuticals is conducting a potentially pivotal clinical trial in the United States and Europe to establish the effectiveness of a drug candidate for combating incurable glioblastoma (“GBM”) brain cancers CNS’s flagship drug candidate is called Berubicin, a product initially developed by another company with encouraging small-population results in 2006, and CNS is expanding the testing with expectations of eventually delivering an innovative new GBM treatment to market The company aims to enroll more than 200 patients in its global Berubicin trial on a 2:1 randomization schema comparing Berubicin-treated patients to those receiving second-line standard of care chemotherapy agent lomustine…

Continue Reading

WednesdayDec 28, 2022 9:00 am

M&A Activity Keeps Flora Growth Corp. (NASDAQ: FLGC) Revenues Strong Amid Expected Rebound in Cannabis Industry

Cannabis cultivator and international brand developer Flora Growth has continued to build its revenues through accretive acquisitions during the past year and expects to see revenues continue to rise amid further M&A activity Flora expects to lock in its latest acquisition by the end of the month after shareholders meet to discuss the proposed deal with multi-national operator Franchise Global Health (“FGH”), which would grant Flora immediate access to Germany’s cannabis market and FGH the ability to overcome supply chain difficulties Flora has previously reported cooperative agreements that increase its product distribution pipeline in Europe through Switzerland and the Czech…

Continue Reading

TuesdayDec 27, 2022 12:00 pm

Lexaria Bioscience Corp. (NASDAQ: LEXX) Uses Patented DehydraTECH(TM) Technology to Increase Bioavailability in Pharmaceuticals

Studies have indicated that around 40% of the available drugs on the market offer poor bioavailability Lexaria’s patented DehydraTECH(TM) technology increases bioavailability, improving the way active pharmaceutical ingredients (“APIs”) enter the bloodstream by promoting more effective oral delivery The global pharmaceutical drug delivery market was valued at $1.66 billion in 2021 and is expected to grow at a CAGR of 5.9%, resulting in a value of $2.21 billion by 2026 One of the main concerns associated with marketed drugs is low bioavailability. Bioavailability is the amount of a drug or substance that becomes completely available to the intended biological destination…

Continue Reading

TuesdayDec 27, 2022 11:15 am

Hillcrest Energy Technologies Ltd. (CSE: HEAT) (OTCQB: HLRTF) Eyes Entry into Grid-Tied Applications; Continues Development of Its Enhanced Powertrain Solution

Hillcrest is poised to accelerate its efforts to expand into grid-tied applications to help diversify future revenue streams; continues development of its Enhanced Powertrain Solution to bridge the gap between EVs and universal, bidirectional charging systems Its unique application-agnostic ZVS inverter technology allows the company to quickly adapt its technology to any motor or grid application, setting it up for entry into renewable energy generation and storage, as well as e-mobility charging Hillcrest’s Enhanced Powertrain Solution is expected to simplify the overall EV powertrain and charging system and free EVs from the need for an onboard charger or additional onboard…

Continue Reading

TuesdayDec 27, 2022 10:30 am

Advisory Firm Appointment Underscores MetAlert, Inc. (MLRT) Strategy Amid Growth Stage and New Patient Location-tracking Technology Rollout

Pioneering GPS-enabled location device developer MetAlert is building on two decades of experience with new products designed to broaden its suite of technology for remote patient monitoring (“RPM”) in an unobtrusive manner plus monitoring seniors for falls MetAlert recently announced that it has engaged the financial strategy advisory firm Joseph Gunnar & Co., LLC to help direct its decisions ranging from acquisitions to potential up listing on a national exchange The company’s products include its flagship patented shoe insole device enabled with GPS, Bluetooth, and Wi-Fi functionality for tracking seniors or people with autism prone to wandering and getting lost,…

Continue Reading

TuesdayDec 27, 2022 9:45 am

Correlate Infrastructure Partners Inc. (CIPI) – Making Energy Transition Efficient, Transparent, and Cost-Effective

Correlate addresses anticipated questions about energy retrofits for the commercial and industrial sector through its industry-leading advanced energy solution and financing platform The company is reducing the overall barrier of entry into the renewable energy space while also aiding in the installation and overall maintenance of high-efficiency infrastructure The company has developed a network of financing partners to cater to project needs, allowing even more customers to access renewable energy solutions for their buildings to reduce their overall carbon footprint, while helping to ensure positive economic return of retrofits in a much shorter timeframe According to the National Renewable Energy…

Continue Reading

Market Basics

New to the micro-cap markets?Get answers to your questions about investing in Small-Cap / Micro-Cap Stocks and learn how to protect yourself.

The Basics

Newsletter Publishers

Have an up and coming newsletter and want to be included in our coverage list? Looking to get more coverage and grow subscriptions? Register for coverage.

Register

Public Companies

Are you a Small-Cap / Micro-Cap company looking for coverage? We'd love to hear from you. Fill out our quick contact form or send us a text.

Get Covered